SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
B7-H3.CD28Z.CART in CNS Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1